UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long‐term monitoring shows hepatitis B virus resistance to entecavir in nucleoside‐naïve patients is rare through 5 years of therapy

Hepatology (Baltimore, Md.), 2009-05, Vol.49 (5), p.1503-1514

2009

Volltextzugriff (PDF)

A novel small molecule inhibitor of hepatitis C virus entry

PLoS pathogens, 2010-09, Vol.6 (9), p.e1001086

2010

Volltextzugriff (PDF)

Inhibition of Hepatitis B Virus Polymerase by Entecavir

Journal of Virology, 2007-04, Vol.81 (8), p.3992-4001

2007

Volltextzugriff (PDF)

In Vitro Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3498-3507

2012

Volltextzugriff (PDF)

Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

Antimicrobial Agents and Chemotherapy, 2007-03, Vol.51 (3), p.902-911

2007

Volltextzugriff (PDF)

Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents

Bioorganic & medicinal chemistry letters, 2013-01, Vol.23 (1), p.198-202

2013

Volltextzugriff (PDF)

Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes

PloS one, 2015-03, Vol.10 (3), p.e0121734-e0121734

2015

Volltextzugriff (PDF)

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

Hepatology (Baltimore, Md.), 2008-05, Vol.47 (5), p.1473-1482

2008

Volltextzugriff (PDF)

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

Journal of hepatology, 2008-06, Vol.48 (6), p.895-902

2008

Volltextzugriff (PDF)

High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virus

PloS one, 2012-08, Vol.7 (8), p.e42609-e42609

2012

Volltextzugriff (PDF)

Inhibitors of HIV-1 attachment. Part 9: An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative

Bioorganic & medicinal chemistry letters, 2013-01, Vol.23 (1), p.209-212

2013

Volltextzugriff (PDF)

In Vivo Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.729-737

2011

Volltextzugriff (PDF)

parC Mutations in Fluoroquinolone-Resistant Borrelia burgdorferi

Antimicrobial Agents and Chemotherapy, 2005-10, Vol.49 (10), p.4354-4357

2005

Volltextzugriff (PDF)

W1805 Entecavir Maintains a High Genetic Barrier to HBV Resistance Through 6 Years in NaïVE Patients

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-865-A-865

2009

Volltextzugriff (PDF)

Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068

Journal of antimicrobial chemotherapy, 2014-03, Vol.69 (3), p.573-581

2014

Volltextzugriff (PDF)

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Hepatology (Baltimore, Md.), 2006-12, Vol.44 (6), p.1656-1665

2006

Volltextzugriff (PDF)

Functionalized triazines as potent HCV entry inhibitors

Bioorganic & medicinal chemistry letters, 2017-02, Vol.27 (4), p.1089-1093

2017

Volltextzugriff (PDF)

Inhibitors of HIV-1 attachment. Part 11: The discovery and structure–activity relationships associated with 4,6-diazaindole cores

Bioorganic & medicinal chemistry letters, 2013-01, Vol.23 (1), p.218-222

2013

Volltextzugriff (PDF)

Impairment of Type I but Not Type III IFN Signaling by Hepatitis C Virus Infection Influences Antiviral Responses in Primary Human Hepatocytes: e0121734

PloS one, 2015-03, Vol.10 (3)

2015

Volltextzugriff (PDF)

A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry: e1001086

PLoS pathogens, 2010-09, Vol.6 (9)

2010

Volltextzugriff (PDF)

Disruption of the Borrelia burgdorferi gac Gene, Encoding the Naturally Synthesized GyrA C-Terminal Domain

Journal of Bacteriology, 2000-04, Vol.182 (7), p.2048-2051

2000

Volltextzugriff (PDF)

Transduction by φBB-1, a Bacteriophage of Borrelia burgdorferi

Journal of bacteriology, 2001-08, Vol.183 (16), p.4771-4778

2001

Volltextzugriff (PDF)

Transduction by phiBB-1, a bacteriophage of Borrelia burgdorferi

Journal of bacteriology, 2001-08, Vol.183 (16), p.4771-4778

2001

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long‐term monitoring shows hepatitis B virus resistance to entecavir in nucleoside‐naïve patients is rare through 5 years of therapy

A novel small molecule inhibitor of hepatitis C virus entry

Inhibition of Hepatitis B Virus Polymerase by Entecavir

In Vitro Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068

Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

Inhibitors of HIV-1 attachment. Part 7: Indole-7-carboxamides as potent and orally bioavailable antiviral agents

Impairment of type I but not type III IFN signaling by hepatitis C virus infection influences antiviral responses in primary human hepatocytes

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virus

Inhibitors of HIV-1 attachment. Part 9: An assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative

In Vivo Patterns of Resistance to the HIV Attachment Inhibitor BMS-488043

parC Mutations in Fluoroquinolone-Resistant Borrelia burgdorferi

W1805 Entecavir Maintains a High Genetic Barrier to HBV Resistance Through 6 Years in NaïVE Patients

Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Functionalized triazines as potent HCV entry inhibitors

Inhibitors of HIV-1 attachment. Part 11: The discovery and structure–activity relationships associated with 4,6-diazaindole cores

Impairment of Type I but Not Type III IFN Signaling by Hepatitis C Virus Infection Influences Antiviral Responses in Primary Human Hepatocytes: e0121734

A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry: e1001086

Disruption of the Borrelia burgdorferi gac Gene, Encoding the Naturally Synthesized GyrA C-Terminal Domain

Transduction by φBB-1, a Bacteriophage of Borrelia burgdorferi

Transduction by phiBB-1, a bacteriophage of Borrelia burgdorferi

Suchergebnisse filtern